🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Terminated
Location
Rocky Mountain Cancer Centers
Start Date
2001-10
Trial ID
NCT00041288
The purpose of this study is to investigate the safety and feasibility of g...
Status
Recruiting
Location
Columbia University Irving Medical Center/NYP
Start Date
2021-10-22
Trial ID
NCT04804891
Treatments Being Tested
This phase I clinical trial evaluates the safety and feasibility of adminis...
Status
Terminated
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2017-07-26
Trial ID
NCT03240861
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Terminated
Location
Mayo Clinic Scottsdale
Start Date
2004-01-22
Trial ID
NCT00052884
RATIONALE: Giving chemotherapy before a peripheral stem cell transplant sto...
Status
Completed
Location
Multiple Locations
Start Date
2001-01
Trial ID
NCT00550784
This randomized phase III trial studies how well imatinib mesylate works in...
Status
Active Not Recruiting
Location
Children's Hospital of Alabama
Start Date
2017-08-08
Trial ID
NCT03007147
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase Ib/II trial studies the side effects of IRX-2, cyclophosphamide,...
Status
Completed
Location
HonorHealth Research Institute
Start Date
2019-04-19
Trial ID
NCT03918499
Treatments Being Tested
At present, all commercially available corneal organ culture media contain ...
Status
Completed
Location
CHU Besançon
Start Date
2012-01
Trial ID
NCT01694914
Treatments Being Tested
The objective of this research is to measure certain indicators of resilien...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2018-09-28
Trial ID
NCT04188678
Treatments Being Tested